Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies

Exploratory Study to Assess Delivery of LMN-201 Components Via Enteric Capsules in the Gut of Individuals With Ostomies

This is a Phase 1, single-site, open label, exploratory study to assess delivery of LMN-201 components via enteric capsules in the gut of individuals with ostomies.

Inclusion Criteria:

• Willing to participate in the clinical trial
• Able and willing to provide informed consent
• Stable ostomy (no revisions in the last 6 months)
• At least 19 years old
• Medically stable, but may be on medications for chronic conditions

Exclusion Criteria:

• Unable or unwilling to provide adequate informed consent
• Non-English speakers
• Clinically significant disease
• Women who are pregnant, intending to become pregnant, or breastfeeding
• Use of anti-diarrheal medicine
• Suffer gastroparesis
• Opioid use